Source: EURLEX
Language: en
Format: md

Judgment of the General Court (Third Chamber) of 6 October 2021 –  
Allergan Holdings France v EUIPO – Dermavita Company (JUVEDERM)

(Case T‑397/20)

(EU trade mark – Revocation proceedings – EU word mark JUVEDERM – Genuine use of the mark – Use in connection with the goods in respect of which the mark is registered – Article 51(1)(a) of Regulation (EC) No 207/2009 (now Article 58(1)(a) of Regulation (EU) 2017/1001))

| 1. | EU trade mark – Lodging of application for EU trade mark – Identification of the goods or services concerned by the trade mark – Use of the general indications in the headings of the classes of the Nice classification – Scope  (Commission Regulation No 2868/95, Art. 1, Rule 2(1))  (see para. 35) |

| 2. | EU trade mark – Surrender, revocation and invalidity – Causes of revocation – Absence of genuine use of a trade mark – Word mark JUVEDERM  (Council Regulation No 207/2009, Arts 51(1)(a) and 57(5))  (see paras 44, 45, 51-53, 56) |

| 3. | EU trade mark – Definition and acquisition of the EU trade mark – Assessment of the registrability of a sign – EU rules only taken into account – Decisions of national authorities not binding EU bodies  (Council Regulation No 207/2009)  (see para. 58) |

Re:

Action brought against the decision of the Fourth Board of Appeal of EUIPO of 14 April 2020 (Case R 877/2019-4), relating to revocation proceedings between Dermavita Company and Allergan Holdings France.

Operative part

The Court:

| 1. | Rejects the plea of inadmissibility; |

| 2. | Dismisses the action; |

| 3. | Orders Allergan Holdings France SAS to bear, in addition to its own costs, the costs incurred by the European Union Intellectual Property Office (EUIPO) and two-thirds of the costs incurred by Dermavita Company S.a.r.l. relating to the present proceedings; |

| 4. | Orders Dermavita Company S.a.r.l. to bear a third of its own costs relating to the present proceedings. |

[Top](#document1)